Literature DB >> 17472586

Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains.

Maho Morishima-Kawashima1, Xianlin Han, Yu Tanimura, Hiroki Hamanaka, Mariko Kobayashi, Takashi Sakurai, Minesuke Yokoyama, Koji Wada, Nobuyuki Nukina, Shinobu C Fujita, Yasuo Ihara.   

Abstract

Apolipoprotein E4 (apoE4) encoded by epsilon 4 allele is a strong genetic risk factor for Alzheimer's disease (AD). ApoE4 carriers have accelerated amyloid beta-protein (A beta) deposition in their brains, which may account for their unusual susceptibility to AD. We hypothesized that the accelerated A beta deposition in the brain of apoE4 carriers is mediated through cholesterol-enriched low-density membrane (LDM) domains. Thus, the concentrations of A beta and various lipids in LDM domains were quantified in the brains of homozygous apoE3 and apoE4 knock-in (KI) mice, and in the brains of those mice bred with beta-amyloid precursor protein (APP) transgenic mice (Tg2576). The A beta 40 and A beta 42 concentrations and the A beta 42 proportions in LDM domains did not differ between apoE3 and apoE4 KI mice up to 18 months of age. The A beta 40 concentration in the LDM domains was slightly, but significantly higher in apoE3/APP mice than in apoE4/APP mice. The lipid composition of LDM domains was modulated in an apoE isoform-specific manner, but its significance for A beta deposition remains unknown. These data show that the apoE isoform-specific effects on the A beta concentration in LDM domains do not occur in KI mouse models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472586      PMCID: PMC2151839          DOI: 10.1111/j.1471-4159.2006.04400.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  61 in total

1.  Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice.

Authors:  H Hamanaka; Y Katoh-Fukui; K Suzuki; M Kobayashi; R Suzuki; Y Motegi; Y Nakahara; A Takeshita; M Kawai; K Ishiguro; M Yokoyama; S C Fujita
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.

Authors:  Jun Yao; Suzana S Petanceska; Thomas J Montine; David M Holtzman; Stephen D Schmidt; Carolyn A Parker; Michael J Callahan; William J Lipinski; Charles L Bisgaier; Brian A Turner; Ralph A Nixon; Ralph N Martins; Charles Ouimet; Jonathan D Smith; Peter Davies; Eugene Laska; Michelle E Ehrlich; Lary C Walker; Paul M Mathews; Sam Gandy
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

3.  Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.

Authors:  Karen M Mann; Fayanne E Thorngate; Yuko Katoh-Fukui; Hiroki Hamanaka; David L Williams; Shinobu Fujita; Bruce T Lamb
Journal:  Hum Mol Genet       Date:  2004-06-30       Impact factor: 6.150

Review 4.  Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples.

Authors:  Xianlin Han; Richard W Gross
Journal:  Mass Spectrom Rev       Date:  2005 May-Jun       Impact factor: 10.946

Review 5.  Lipoproteins in the central nervous system.

Authors:  M J Ladu; C Reardon; L Van Eldik; A M Fagan; G Bu; D Holtzman; G S Getz
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

6.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

7.  Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice.

Authors:  Hideki Hayashi; Urule Igbavboa; Hiroki Hamanaka; Mariko Kobayashi; Shinobu C Fujita; W Gibson Wood; Katsuhiko Yanagisawa
Journal:  Neuroreport       Date:  2002-03-25       Impact factor: 1.837

8.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging.

Authors:  M Enya; M Morishima-Kawashima; M Yoshimura; Y Shinkai; K Kusui; K Khan; D Games; D Schenk; S Sugihara; H Yamaguchi; Y Ihara
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more
  3 in total

Review 1.  Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.

Authors:  Xianlin Han
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Apolipoprotein E ε4 Mediates Myelin Breakdown by Targeting Oligodendrocytes in Sporadic Alzheimer Disease.

Authors:  Gerald Wai-Yeung Cheng; Kingston King-Shi Mok; Sunny Hoi-Sang Yeung; Julia Kofler; Karl Herrup; Kai-Hei Tse
Journal:  J Neuropathol Exp Neurol       Date:  2022-08-16       Impact factor: 3.148

Review 3.  ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease.

Authors:  Maria Fe Lanfranco; Christi Anne Ng; G William Rebeck
Journal:  Int J Mol Sci       Date:  2020-09-01       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.